FROM INSIGHT TO EXECUTION
Strategy that prioritizes clarity, alignment, and execution in complex environments. Engagements are hands-on, outcome-driven, and designed to support confident decision-making in the real world.

REGAINING
MOMENTUM
CHALLENGE: Despite strong mission alignment, political and industry headwinds slowed deal velocity in 1H 2025 and reduced sponsor confidence due to unclear pricing and inconsistent value articulation.
​
SOLUTION: Redesigned pricing and messaging through a strategy audit, creating a scalable pricing framework and ROI narrative tied to pharma sponsor related key performance indicators (KPIs).
​
IMPACT POST ENGAGMENT:
58%
38%
28%
of executed deals closed in Q3 alone
of year-end pipeline emerged in 2H 2025
YoY increase in total sales from 2024

CLIENTS & PARTNERS
ACADEMIC
INSTITUTIONS:


BIOTECH & STARTUPS:


VENTURE CAPITAL:

INDUSTRY
TITANS:













.png)